Cargando cotizaciones...
Previsión
No hay datos de analistas disponibles para esta empresa.
Debates en la comunidad
Todavía no hay ninguna discusión sobre este activo.
Iniciar debateNoticias Ir al feed de noticias
SKAN: CFO and division head to face Federal Criminal Court over suspicion of insider trading
Two senior employees of SKAN must answer to the Federal Criminal Court on suspicion of insider trading. The trial begins on 5 November, and the first-instance verdict is to be announced on 17 November. The CFO is alleged to have bought shares before the IPO and to have gained an alleged benefit of around 287,000 francs; the division head is accused of obtaining a benefit of about 5,600 francs. The board emphasizes the presumption of innocence and expresses its confidence in the managers; both remain in their positions. Proceedings against former board chairman Gert Thoenen were discontinued. » Más en finanzen.net
SKAN reports strong half-year results and returns to profit
SKAN increased net revenues in 1H 2026 by 22.2% to CHF 164.5m (currency-adjusted +24.0%) and swung from a net loss of CHF 8.3m to a net profit of CHF 5.4m (EPS CHF 0.21). EBITDA rose to CHF 15.3m, operating cash flow to CHF 16.3m; order intake grew 16.3% to CHF 247.6m, and the order backlog increased 27.8% to CHF 442.3m. The Services & Consumables segment recorded an order intake increase of over 54%, and acquisitions contributed to results for the first time on a full-year basis. Management confirmed the annual guidance, expecting net sales growth in the high-teens percentage range and an EBITDA margin of 13–15%. » Más en de.investing.com
SKAN increases order intake and net sales significantly and confirms full-year guidance
SKAN reports double-digit growth in the first half of 2026: order intake +16.3% to CHF 247.6m, order backlog +27.8% to CHF 442.3m and net sales +22.2% to CHF 164.5m. EBITDA rose to CHF 15.3m and the half-year profit amounted to CHF 5.4m. SKAN confirms its 2026 guidance, forecasting net sales growth in the high single-digit/upper ten-percent range and an EBITDA margin of 13–15%, and sees further growth opportunities thanks to a strong market position. » Más en de.investing.com
SKAN Group records decline in sales and earnings in 2025
The Basel-based SKAN Group posted lower revenue and earnings in the 2025 fiscal year, as expected. The figures are therefore below the previous year’s level. » Más en finanzen.net
SKAN: declining revenues and earnings in fiscal year 2025
The Basel-based SKAN Group reports preliminary, unaudited figures for fiscal year 2025 showing falling revenue and reduced earnings. The company provides more details in the full AWP release. » Más en finanzen.net
Dividendos históricos Dividendos
Todas las métricas de dividendos Todas las métricasDatos financieros de la empresa
| (EUR) | junio de 2026 | YoY |
|---|---|---|
| Ingresos | 178,19 M | - |
| Beneficio bruto | 126,32 M | - |
| Beneficio neto | 5,21 M | - |
| EBITDA | 19,37 M | - |
Datos fundamentales
| Métrica | Valor |
|---|---|
Capitalización bursátil | 1686,49 M € |
Número de acciones | 22,48 M |
Máximo/mínimo de 52 semanas | 83,78 € - 38,70 € |
Rentabilidad por dividendo | 0,32 % |
Dividendos TTM | 0,24 € |
Beta | 0,79 |
Ratio P/E | 52,11 |
Ratio PEG | 0,62 |
Ratio P/B | 13,70 |
Ratio P/S | 4,29 |
Perfil de la empresa
SKAN Group AG suministra aisladores, dispositivos para salas limpias y procesos de descontaminación para las industrias farmacéutica y química en Asia, Europa, el continente americano e internacionalmente. Opera en dos segmentos: Equipos y Soluciones (E&S) y Servicios y Consumibles (S&C). El segmento E&S ofrece soluciones de misión crítica para la producción farmacéutica, incluidos aisladores, sistemas automatizados integrados y sistemas y soluciones de llenado aséptico, así como equipos de laboratorio y de salas limpias. El segmento S&C proporciona soporte para el ciclo de vida y consumibles listos para usar, así como soluciones específicas para clientes y soluciones digitales. La empresa era anteriormente conocida como BV Holding AG y cambió su nombre a SKAN Group AG en octubre de 2021. SKAN Group AG fue fundada en 1968 y tiene su sede en Allschwil, Suiza.
| Nombre | SKAN Group N |
| CEO | Jonas Greutert |
| Sede | Allschwil,
bl Suiza |
| Sitio web | |
| Sector | Salud |
| Industria | Productos farmacéuticos |
| Salida a bolsa | 28/12/2021 |
| Empleados | 1694 |
Símbolos bursátiles
| Bolsa | Símbolo |
|---|---|
SIX | SKAN.SW |
London | 0SKN.L |